Results 51 to 60 of about 1,766,485 (324)

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu   +9 more
wiley   +1 more source

Financial management engagement and small and medium-sized businesses in eThekwini municipality, South Africa

open access: yesEconomics, Management and Sustainability
Small and medium-sized businesses are widely recognised as the cornerstone of growth in emerging and middle-class countries, and South Africa is no different.
Kansilembo Aliamutu, Msizi Mkhize
doaj   +1 more source

Investigating Some of Effective Factors on Spoofing Manipulation in Iranian Stock Market [PDF]

open access: yesتحقیقات مالی, 2018
Objective: There is a large theoretical literature regarding stock market manipulation. However, empirical evidence of manipulation remains scare especially in emerging markets like Iran. So, it is vital to detect and prevent.
Mohammad Nadiri   +3 more
doaj   +1 more source

Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aging population of people with HIV (PWH) raises heightened concerns regarding accelerated aging and dementia. Portable, low‐field MRI (LF‐MRI) is an innovative technology that could enhance access and facilitate routine monitoring of PWH.
Annabel Sorby‐Adams   +14 more
wiley   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Evolution of transport, accessibility and tourism competitiveness in Extremadura (Spain): a benchmarking analysis

open access: yesEuropean Transport Research Review
The efficiency of the transportation options available to tourists, in terms of convenience and time, directly impacts the competitiveness of a destination in the tourism sector. The aim of this study is to compare how the indicators of accessibility and
Marcelino Sánchez-Rivero   +3 more
doaj   +1 more source

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang   +7 more
wiley   +1 more source

Estimation of default and pricing for invoice trading (P2B) on crowdlending platforms

open access: yesFinancial Innovation
This study developed several machine learning models to predict defaults in the invoice-trading peer-to-business (P2B) market. Using techniques such as logistic regression, conditional inference trees, random forests, support vector machines, and neural ...
Cristian Marques Corrales   +2 more
doaj   +1 more source

Environmental Financial Accounting [PDF]

open access: yes
From a company’s perspective, there seem to be two underlying forces driving company interest in various kinds of environmental performance data that might be considered varieties of accounting.
Florentina Moisescu, Oana Anghel
core  

Home - About - Disclaimer - Privacy